ResearcherWannan Medical CollegeActive in the last 2 years

Xiaosan Fang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5032028666. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications. Last author DOI 10.2147/ijn.s466459 ↗
Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic cancer cells. Co-author DOI 10.3892/ol.2020.11469 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuan Pan · 1 shared paper, 2024 · strength 0.28
- Paper Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications. DOI 10.2147/ijn.s466459 ↗
Shihang Xi · 1 shared paper, 2020 · strength 0.13
- Paper Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic … DOI 10.3892/ol.2020.11469 ↗
Peng Chen · 1 shared paper, 2020 · strength 0.13
- Paper Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic … DOI 10.3892/ol.2020.11469 ↗
Xiaoming Wang · 1 shared paper, 2020 · strength 0.13
- Paper Silencing of keratin 17 by lentivirus-mediated short hairpin RNA inhibits the proliferation of PANC-1 human pancreatic … DOI 10.3892/ol.2020.11469 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.